Gilead signs remdesivir agreement with European Commission
Under the terms of the contract, Gilead will supply the EC with up to half a million treatment courses of Veklury to treat COVID-19 patients.
Archives for October 13, 2020
hyperCORE names new CEO
The clinical research site network has tapped 22-year industry veteran Karri Venn, president of research with LMC Manna, to lead the organization.
First COVID-19 patient treated in Noxopharm study
The clinical-stage drug development company has kicked off testing the experimental anticancer drug Veyonda on severe patients in a Phase I trial.